Chris Cline is the Chief Financial Officer at Travere Therapeutics, where he has held progressing roles since 2014, starting in investor relations. A Chartered Financial Analyst, he holds a BSBA from Xavier Universitys Williams College of Business and has prior experience at Elan Corporation and Phase Forward.
He is passionate about developing and delivering innovative treatments to people living with rare diseases, a commitment reflected in his companys mission and his own public statements.
His career path is unique, having advanced from leading investor relations and corporate communications to becoming the companys CFO.
Read the full overview →Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.